Skye Bioscience News Today

Cantor Fitzgerald started coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $21.00 price target on the stock. SKYE has been the subject of a number of other research reports. Piper Sandler reissued an overweight rating and […]

Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its profitability, dividends, risk, earnings, valuation, institutional ownership and analyst recommendations. Valuation & Earnings This table […]

Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 992 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its valuation, institutional ownership, dividends, analyst recommendations, risk, profitability and earnings. Insider & Institutional Ownership 21.1% […]

BioPharma

Skye Bioscience Stock (NASDAQ: SKYE) stock price, news, charts, stock research, profile.

SKYE BIOSCIENCE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS ...

Financing expected to fund strategic expansion of obesity clinical development and extend operating runway beyond 2026San Diego, California--(News...

Piper Sandler assumed coverage on shares of Skye Bioscience (OTCMKTS:SKYE – Free Report) in a research report released on Monday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $12.00 price target on the stock. Skye Bioscience Stock Performance OTCMKTS:SKYE opened at $4.90 on Monday. The firm has a market capitalization of $60.52 […]

Skye Bioscience, Inc. , a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid...

Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report)’s stock price shot up 8.6% on Friday . The company traded as high as $4.04 and last traded at $4.01. 4,485 shares changed hands during trading, a decline of 0% from the average session volume of 4,486 shares. The stock had previously closed at $3.69. Skye Bioscience […]